BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 29
• 30
• 31

• Drug Development

  Exelixis, Inc. Expands the Cabozantinib Development Program Through NCI-CTEP Collaboration

  May 3, 2012

   · 

  1 min read
• Business

  ArQule, Inc. Reports First Quarter 2012 Financial Results

  May 3, 2012

   · 

  1 min read
• Business

  Sue Paish Named CEO of LIFElab

  May 3, 2012

   · 

  2 min read
• Business

  Nanosonics to Raise $12 Million

  May 3, 2012

   · 

  1 min read
• Drug Development

  FibroGen, Inc. Announces Promising Preliminary Data from an Open-label Phase 2 Study to Evaluate the Safety and Efficacy of FG-3019 in Individuals With Idiopathic Pulmonary Fibrosis (IPF) and Provides Program Update

  May 3, 2012

   · 

  1 min read
• Prima Biomed to Present at the 37th Annual Deutsche Bank Health Care Conference

  May 3, 2012

   · 

  1 min read
• Lundbeck Inc. Eyes Pipeline as Key Antidepressant Fades

  May 3, 2012

   · 

  1 min read
• Business

  Interleukin Genetics Inc. Announces Conference Call to Discuss First Quarter 2012 Results

  May 3, 2012

   · 

  1 min read
• Business

  Momenta Pharmaceuticals, Inc. Reports First Quarter 2012 Financial Results

  May 3, 2012

   · 

  1 min read
• Business

  Symmetry Medical Inc. Reports First Quarter 2012 Financial Results

  May 3, 2012

   · 

  1 min read